Outcomes of Human Papilloma Virus Vaccination in a Private Women Health Clinic in Lebanon

Table 3

Recurrence of CIN lesions in women who received the human papilloma virus vaccine at the Women’s Health Center (WHC) of the American University of Beirut-Medical Center (AUBMC) 2007–2017.

	Outcomes of lesions			Value	Relative risk for recurrence CIN2+
	CIN2+	<CIN2+	Total
NS2 group (n = 267)	1	9	10	0.99	0.3% (1/267)
SA^+ group (n = 174)	1	29	30		0.5% (1/174)

NS2: not previously sexually active at the time of first dose of vaccination; +SA: sexually active before first dose of vaccination.